SCHEMBL16626435

SCHEMBL16626435

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3ccc(C#N)cc3Cl)ccc12

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.39
BACE2 Q9Y5Z0 1/20 0.39
HTR6 P50406 5/20 0.39
CNR2 P34972 2/20 0.37
IDE P14735 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
FBP1 P09467 2/20 0.35
NAMPT P43490 2/20 0.34
PDE5A O76074 1/20 0.34
SRC P12931 1/20 0.34
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
ALPL P05186 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619036 0.99 LRRK2 (0.39) LRRK2BACE2HTR6CNR2IDE
SCHEMBL16626406 0.91 HTR6 (0.39) HTR6IDEPDE4APDE4BPDE4C
SCHEMBL16626407 0.91 HTR6 (0.39) LRRK2HTR6IDEPDE4APDE4B
SCHEMBL16626684 0.90 HTR6 (0.39) BACE2HTR6IDENAMPTPTGS1
Hydrochloric Acid SCHEMBL16619163 0.90 HTR6 (0.39) HTR6IDEPDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL16618890 0.90 HTR6 (0.39) LRRK2HTR6IDEPDE4APDE4B
SCHEMBL16626428 0.90 HTR6 (0.41) HTR6CNR2IDEPDE4APDE4B
Hydrochloric Acid SCHEMBL16619391 0.90 HTR6 (0.38) BACE2HTR6IDENAMPTPTGS1
Hydrochloric Acid SCHEMBL16619520 0.89 HTR6 (0.40) HTR6CNR2IDEPDE4APDE4B
SCHEMBL16618670 0.89 NAMPT (0.41) HTR6IDEPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI LRRK2 1918/4885BACE2 3753/4885HTR6 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.